Jingying Xu

CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

Jingying Xu, Jemima Escamilla, Stephen Mok et al. · Cancer Research · 2013 · 561 citations

Medicine, Immunology, Oncology +17

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 350 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Xiuli Wang, Leslie Popplewell, Jamie R. Wagner et al. · Blood · 2016 · 330 citations · Full text

Life Sciences, Hematology, Immunology +14

Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy

Stephen Mok, Richard C. Koya, Christopher Tsui et al. · Cancer Research · 2013 · 318 citations · Full text

Medicine, Immunology, Oncology +17

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary et al. · The Lancet Oncology · 2020 · 301 citations

Medicine, Oncology, Pharmacology +15